Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Epidermoid cysts (EC) are benign cystic lesions lined by squamous epithelium resulting from entrapped ectodermal elements during development. These can occur in various anatomic locations, including intracranial, intradiploic, spinal and in the superficial soft tissues. Although benign, these can grow or rupture, and mimic malignant tumor or infection. Here, we describe the case of an 8-month-old male with cutaneous Langerhans cell histiocytosis (LCH) presenting with a lytic calvarial lesion initially thought to be osseous involvement of LCH. Further workup revealed imaging findings discordant with this diagnosis and instead suggestive of an intradiploic EC which was subsequently confirmed with pathology. This case illustrates the importance of keeping the differential diagnosis broad and re-evaluating the diagnosis based on the imaging appearance despite the presumptive diagnosis provided clinically.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12205736PMC
http://dx.doi.org/10.1016/j.radcr.2025.05.041DOI Listing

Publication Analysis

Top Keywords

langerhans cell
8
cell histiocytosis
8
growing intradiploic
4
intradiploic epidermoid
4
epidermoid cyst
4
cyst presenting
4
presenting diagnostic
4
diagnostic challenge
4
challenge setting
4
setting langerhans
4

Similar Publications

Erdheim-Chester disease (ECD) is a rare systemic non-Langerhans cell histiocytosis with multiple organ involvement. Being a rare disease with variable clinical manifestations, it is often difficult to diagnose. F-2-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) plays a vital role in assessing disease extent and severity, diagnosis, treatment response and is a potential biomarker for BRAF mutation.

View Article and Find Full Text PDF

Background: The expression and clinical correlation of BRAFV600E mutation and programmed cell death-1 ligand 1 (PD-L1) in children with Langerhans cell histiocytosis (LCH) have been reported, but the conclusions of previous studies are inconsistent. In addition, it has been reported that elevated cathepsin S (CTSS) expression is associated with various cancers. However, there is currently no research on the correlation between CTSS and LCH.

View Article and Find Full Text PDF

Purpose: In children with Langerhans Cell Histiocytosis (LCH), FDG-PET/CT is used for staging and response assessment. Whole-body MRI (WB-MRI) can serve as an ionizing radiation-free alternative for repeated whole-body imaging. The aim of this study was to compare WB-MRI with FDG-PET/CT for staging and response assessment in pediatric LCH.

View Article and Find Full Text PDF

Langerhans cell histiocytosis is a relatively rare disease. This article explores the clinicopathological features, differential diagnosis, and biological characteristics of Langerhans cell histiocytosis. A comprehensive analysis was conducted on the clinical data, clinical characteristics, histological observations, immunohistochemical studies, pathological features, treatment, and prognosis of one case of Langerhans cell histiocytosis occurring in the temporal bone, to enhance clinical understanding of this disease.

View Article and Find Full Text PDF

Pancreatic Islet Cell Hormones: Secretion, Function, and Diabetes Therapy.

MedComm (2020)

September 2025

Department of Endocrinology and Metabolism, Center for Diabetes and Metabolism Research, Division of Pancreatic Surgery, Department of General Surgery, Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, West China Hospital Sichuan University Chen

The pancreatic islets of Langerhans, which are composed of α, β, δ, ε, and PP cells, orchestrate systemic glucose homeostasis through tightly regulated hormone secretion. Although the precise mechanisms involving β cells in the onset and progression of diabetes have been elucidated and insulin replacement therapy remains the primary treatment modality, the regulatory processes, functions, and specific roles of other pancreatic islet hormones in diabetes continue to be the subject of ongoing investigation. At present, a comprehensive review of the secretion and regulation of pancreatic islet cell hormones as well as the related mechanisms of diabetes is lacking.

View Article and Find Full Text PDF